On the other hand, no substantial alteration in γδ T lymphocyte CD69 expression is observed in patients with severe COVID-19 compared to non-COVID-19 patients, suggesting that this state of activation could be a general reflection of a severe condition, rather than a specific feature of SARS-CoV-2 infection [48,49]. This evidence concerns the gene CD69 and COVID-19.